Cooper Steven J, Ridley Emma T
Kissileff Laboratory for the Study of Human Ingestive Behaviour, School of Psychology, University of Liverpool, Liverpool L69 7ZA, UK.
Pharmacol Biochem Behav. 2005 Jul;81(3):517-23. doi: 10.1016/j.pbb.2005.02.014.
Effects of the anxioselective anxiolytic abecarnil, a beta-carboline benzodiazepine-receptor agonist, on initial licking responses for a 3% sucrose solution and on taste reactivity responses were evaluated in adult male rats. The rats' behaviour was video recorded, and analysed according to a frame-by-frame procedure to generate the durations of categorized fixed action patterns, and the number and rate of licking responses. The results indicated that abecarnil (0.3-3.0 mg/kg, i.p.) significantly increased the number of licks in the first continuous sample of licking, while significantly reducing the lick rate (licks/s). Additionally, abecarnil selectively enhanced positive ingestive responses, but had no effect on either neutral or aversive response categories in taste reactivity measures. On the basis on this pattern of results, we conclude that abecarnil can enhance taste palatability selectively, and that it may act as an agonist at GABA(A) benzodiazepine receptor subtypes which mediate drug effects on ingestive behaviour.
在成年雄性大鼠中评估了抗焦虑选择性抗焦虑药阿贝卡尼(一种β-咔啉苯二氮䓬受体激动剂)对3%蔗糖溶液初始舔舐反应和味觉反应性反应的影响。对大鼠的行为进行视频记录,并按照逐帧程序进行分析,以得出分类的固定动作模式的持续时间以及舔舐反应的次数和速率。结果表明,阿贝卡尼(0.3 - 3.0毫克/千克,腹腔注射)显著增加了首次连续舔舐样本中的舔舐次数,同时显著降低了舔舐速率(舔舐次数/秒)。此外,阿贝卡尼选择性增强了积极的摄食反应,但对味觉反应性测量中的中性或厌恶反应类别均无影响。基于这种结果模式,我们得出结论,阿贝卡尼可以选择性增强味觉适口性,并且它可能作为介导药物对摄食行为影响的GABA(A)苯二氮䓬受体亚型的激动剂发挥作用。